Page 4,833«..1020..4,8324,8334,8344,835..4,8404,850..»

Blind Florida running back reaches the end zone during game

Posted: Published on October 18th, 2013

Davonte Pollard can only see colors. Diagnosed as a 9-year-old with retinitis pigmentosa, the Braddock High (Miami, Fla.) senior running back is legally blind, as brought to Prep Rally's attention in a Miami Herald feature. Still, he can see the open green grass amid the sea of Bulldogs blue and white crashing against the blue and gold of crosstown rival Coral Park. And that's all he needed. Leading 52-21 late in the fourth quarter, Braddock coach Frank Rojas ran a no-huddle offense, resulting in a touchdown as time expired, the Herald reported. He called Pollard's number (50) for the 2-point conversion attempt, and the senior plunged it in on a play called "47 stretch" for the 60-21 final -- the Bulldog's lone victory of the season. "After the game we were shaking hands, and I was so excited my hand was shaking," Pollard told the paper. "Everybody was happy for me; everybody was giving me hugs." Pollard's earlier conversion attempt failed when "he took a good lick," but he wouldn't be denied on the game's final play -- one that actually set him in motion in the backfield. Pollard reportedly only had two rushing attempts since joining the team as … Continue reading →

Posted in Retinitis Pigmentosa | Comments Off on Blind Florida running back reaches the end zone during game

Stem cell transplant repairs damaged gut in mouse model of inflammatory bowel disease

Posted: Published on October 18th, 2013

PUBLIC RELEASE DATE: 17-Oct-2013 Contact: Jen Middleton j.middleton@wellcome.ac.uk 44-207-611-7262 Wellcome Trust A source of gut stem cells that can repair a type of inflammatory bowel disease when transplanted into mice has been identified by researchers at the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute at the University of Cambridge and at BRIC, the University of Copenhagen, Denmark. The findings pave the way for patient-specific regenerative therapies for inflammatory bowel diseases such as ulcerative colitis. All tissues in our body contain specialised stem cells, which are responsible for the lifelong maintenance of the individual tissue and organ. Stem cells found in adults are restricted to their tissue of origin, for example, stem cells found in the gut will be able to contribute to the replenishment of the gut whereas stem cells in the skin will only contribute to maintenance of the skin. The team first looked at developing intestinal tissue in a mouse embryo and found a population of stem cells that were quite different to the adult stem cells that have been described in the gut. The cells were very actively dividing and could be grown in the laboratory over a long period without becoming specialised into the adult … Continue reading →

Posted in Stem Cell Transplant | Comments Off on Stem cell transplant repairs damaged gut in mouse model of inflammatory bowel disease

Advanced Cell Technology to Webcast 2013 Annual Shareholders’ Meeting on Tuesday, October 22nd

Posted: Published on October 18th, 2013

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Advanced Cell Technology, Inc. (ACT)(ACTC), a leader in the field of regenerative medicine, announced today that it will webcast its Annual Shareholders Meeting to be held on Tuesday, October 22nd at the Hyatt Regency Suites, Palm Springs, 285 N. Palm Canyon Drive, Palm Springs, Calif. The meeting is open to shareholders of record as of August 23, 2013. The webcast will begin at 9 a.m. PDT, after the Company completes the formal portion of the meeting, where results of proxy voting will be announced. At that time, members of the management team will deliver a Company presentation and address questions from shareholders. Questions will be taken from both members of the live audience as well as electronically from the webcast. The webcast will be available live and for replay by webcast at: http://us.meeting-stream.com/advancedcelltechnology102213 About Advanced Cell Technology, Inc. Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. The company is conducting various clinical trials for treating macular degeneration, and has a preclinical development pipeline focused on products for eye diseases, autoimmune and inflammatory diseases, and wound healing. Its intellectual … Continue reading →

Posted in Stem Cell Human Trials | Comments Off on Advanced Cell Technology to Webcast 2013 Annual Shareholders’ Meeting on Tuesday, October 22nd

Research and Markets: Global Stem Cells Market Report 2013-2018: Adult Stem Cells, Human Embryonic Stem Cells and …

Posted: Published on October 18th, 2013

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/7ntlsl/stem_cells_market) has announced the addition of the "Global Stem Cells Market Report 2013-2018" report to their offering. Stem Cells Market (Adult, Human Embryonic , Induced Pluripotent, Rat-Neural, Umbilical Cord, Cell Production, Cell Acquisition, Expansion, Sub-Culture) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018 The market by products is segmented into three sub-types, namely adult stem cells, human embryonic stem cells and other type of stem cells. Adult stem cells are further segmented into hematopoietic stem cells, mesenchymal stem cells, neuronal stem cells, dental stem cells and umbilical cord stem cells. The other types of stem cells include induced pluripotent stem cells, natural rosette cells and very small embryonic like stem cells. The report highlights the market shares of key players in 2011. The company profiles for some of the key players, namely Advanced Cell Technology Inc., STEMCELL Technologies Inc., Cellular Engineering Technologies Inc., BioTime Inc., Aastrom Biosciences Inc. and California Stem Cell Inc. in terms of company overview, financial overview, business strategies, recent developments and product portfolio is also covered. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Stem Cells Market, … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Research and Markets: Global Stem Cells Market Report 2013-2018: Adult Stem Cells, Human Embryonic Stem Cells and …

MDA teams up with Phoenix Children's Hospital for their own Taste of the Town

Posted: Published on October 17th, 2013

PHOENIX - The Muscular Dystrophy Association will hold its Taste of the Town fundraising event at Scottsdale Quarter on Friday. Robert Reed was diagnosed with muscular dystrophy at age 8. He received care at the Barrow Neurological Institute at Phoenix Children's Hospital. "When I was diagnosed, my family didn't have medical insurance, so MDA was there to provide free doctor care and helping me get diagnosed and getting the treatment that I needed," he said. Thanks to MDA, Robert also attended summer camp and discovered wheelchair basketball. He's a member of the Banner wheel chair Suns and also coaches the junior team. Now 22, Robert is an advocate for other kids and families battling the disease. "As a kid, I didn't necessarily understand what was going on, but for my parents, it was really important to be able to talk to other parents that were going through the exact same thing," he said. Taste of the Town is one of the biggest fundraising events MDA hosts locally. It will feature over 25 food and wine vendors, live music and a silent auction. "What they're doing in this event and raising money.. it will go to help not only myself, but … Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on MDA teams up with Phoenix Children's Hospital for their own Taste of the Town

Parent Project Muscular Dystrophy and Sarepta Therapeutics Join Forces on Genetic Testing Program for Patients With …

Posted: Published on October 17th, 2013

HACKENSACK, NJ and CAMBRIDGE, MA--(Marketwired - Oct 17, 2013) - Parent Project Muscular Dystrophy (PPMD) and Sarepta Therapeutics, Inc. (NASDAQ: SRPT) today announced a new nationwide program from PPMD to assist individuals with Duchenne muscular dystrophy in accessing genetic testing. The program will be administered by PPMD, a leading voice for patients and families impacted by Duchenne. Support for the initiative will be provided by Sarepta, a developer of innovative RNA-based therapeutics. Through the new program, called Decode Duchenne, PPMD will offer genetic testing at no cost to eligible patients who are unable to access testing due to barriers such as a lack of or insufficient insurance coverage. Decode Duchenne is expected to launch in the fourth quarter of 2013 through PPMD's DuchenneConnect, an online resource and registry for patients and families affected by Duchenne and their healthcare providers. For patients with Duchenne, genetic testing is used to identify the genetic mutation and confirm the diagnosis. In addition, genetic testing can be used to determine a patient's eligibility for certain clinical trials. Despite the potential benefits of testing, in some cases patients are unable to access genetic testing through their insurance provider. "We believe all patients with Duchenne should have … Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on Parent Project Muscular Dystrophy and Sarepta Therapeutics Join Forces on Genetic Testing Program for Patients With …

Isis Pharma up on muscular dystrophy drug payment

Posted: Published on October 17th, 2013

Home Mail News Sports Finance Weather Games Groups Answers Screen Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Mobile Yahoo News Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo News Home Video Photos GMA Year in Review Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Sideshow Katie's Take Power Players This Could Be Big Newsmakers Trending Now The Upbeat Who Knew? … Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on Isis Pharma up on muscular dystrophy drug payment

RTI International Continues Development of Mobile Seizure Alert System for Epilepsy Patients

Posted: Published on October 17th, 2013

Newswise RESEARCH TRIANGLE PARK, N.C. Approximately 2 million people, including 400,000 children, in the United States are being treated for epilepsy, and one-third continue to have seizures despite treatment. In order to address an important caregiver need, RTI International has been developing a prototype mobile seizure alert system to help epilepsy patients and their families cope with seizures. RTI researchers received a $1.6 million grant from the National Institutes of Health to accelerate the development of this device concept and validation in clinical settings. A major concern of people with epilepsy and their family is the possibility that an unwitnessed seizure might cause serious injury, loss of consciousness, or even death, said Barbara Kroner, Ph.D., senior epidemiologist at RTI and co-principal investigator of the project. She is also the mother of a child with uncontrolled seizures. There are presently no reliable home-based monitoring devices available in the United States to assist caregivers with this task, which can result in significant alterations to the familys life routine and stress level. Parents or siblings of children with nocturnal seizures often find themselves sleeping in the same room or even in the same bed with the child in case a seizure occurs. RTIs … Continue reading →

Comments Off on RTI International Continues Development of Mobile Seizure Alert System for Epilepsy Patients

Lundbeck Launches Support Program for Parents of Children with Infantile Spasms

Posted: Published on October 17th, 2013

DEERFIELD, Ill.--(BUSINESS WIRE)-- UnderStanding Together was launched today for parents of children with infantile spasms (IS), a difficult form of epilepsy that usually affects children between the ages of four and eight months.1 This Lundbeck program connects parents coping with this diagnosis with others who have faced similar challenges and have experience with Lundbecks treatment for IS, SABRIL (vigabatrin). By calling 855-417-7859, families can enroll in the program to speak on the phone with another parent who has a child with infantile spasms. A diagnosis of infantile spasms can be overwhelming, making treatment decisions very difficult. Recommendations issued by the National Organization for Rare Diseases (NORD),2 the American Academy of Neurology (AAN)3 and the Tuberous Sclerosis (TS) Alliance4 all agree that infantile spasms be diagnosed as early as possible and managed with one of two approved treatments. SABRIL is approved by the U.S. Food and Drug Administration as monotherapy for pediatric patients one month to two years of age with infantile spasms for whom the potential benefits outweigh the potential risk of permanent vision loss.5,6 In evaluating whether to start SABRIL, doctors and parents work together to assess the risk of vision loss versus the benefit of the medication. There … Continue reading →

Comments Off on Lundbeck Launches Support Program for Parents of Children with Infantile Spasms

Texas State Grant Funds Autism Treatment – Video

Posted: Published on October 17th, 2013

Texas State Grant Funds Autism Treatment The Center for Autism and Related Disorders has received a $750000 grant from the Texas Department of Assistive and Rehabilitative Services. The money will ... By: Center for Autism and Related Disorders … Continue reading →

Comments Off on Texas State Grant Funds Autism Treatment – Video

Page 4,833«..1020..4,8324,8334,8344,835..4,8404,850..»